Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis
Stopped Terminated: Study in Behcet's disease with mostly active uveitis did not meet its primary endpoint.
Conditions
Interventions
- DRUG: AIN457
- DRUG: AIN457
- DRUG: AIN457
- DRUG: Placebo
Sponsor
Novartis Pharmaceuticals